# American Water Works Company, Inc.: financial statements, quarterly

AWK · NYSE · CIK 1410636 · [Utilities](/sectors/utilities.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/awk.md) · [Financials](/companies/awk/financials.md) · [Filings](/companies/awk/filings.md) · [Insiders](/companies/awk/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/awk/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,170](/filings/0001410636-24-000187.md) | [1,032 d](/filings/0001410636-26-000034.md) | [1,003](/filings/0001410636-25-000083.md) | [1,140](/filings/0001410636-25-000150.md) | [1,328](/filings/0001410636-25-000173.md) | [1,178 d](/filings/0001410636-26-000034.md) | [1,134](/filings/0001410636-26-000063.md) | [1,272](/filings/0001410636-26-000120.md) | [1,454](/filings/0001410636-25-000173.md) | [1,266 d](/filings/0001410636-26-000034.md) | [1,203](/filings/0001410636-26-000063.md) | [1,350](/filings/0001410636-26-000120.md) |
| Operating income | $m | [478](/filings/0001410636-25-000022.md) | [299](/filings/0001410636-25-000022.md) | [326](/filings/0001410636-25-000083.md) | [449](/filings/0001410636-25-000150.md) | [543](/filings/0001410636-25-000173.md) | [400](/filings/0001410636-25-000022.md) | [371](/filings/0001410636-26-000063.md) | [489](/filings/0001410636-26-000120.md) | [614](/filings/0001410636-25-000173.md) | [405 d](/filings/0001410636-26-000034.md) | [391](/filings/0001410636-26-000063.md) | [542](/filings/0001410636-26-000120.md) |
| Interest expense | $m | [117](/filings/0001410636-24-000187.md) | [118 d](/filings/0001410636-26-000034.md) | [124](/filings/0001410636-25-000083.md) | [131](/filings/0001410636-25-000150.md) | [132](/filings/0001410636-25-000173.md) | [136 d](/filings/0001410636-26-000034.md) | [144](/filings/0001410636-26-000063.md) | [151](/filings/0001410636-26-000120.md) | [158](/filings/0001410636-25-000173.md) | [162 d](/filings/0001410636-26-000034.md) | [163](/filings/0001410636-26-000063.md) | [167](/filings/0001410636-26-000120.md) |
| Income tax | $m | [84.0](/filings/0001410636-24-000187.md) | [47.0 d](/filings/0001410636-26-000034.md) | [57.0](/filings/0001410636-25-000083.md) | [84.0](/filings/0001410636-25-000150.md) | [103](/filings/0001410636-25-000173.md) | [64.0 d](/filings/0001410636-26-000034.md) | [65.0](/filings/0001410636-26-000063.md) | [87.0](/filings/0001410636-26-000120.md) | [115](/filings/0001410636-25-000173.md) | [44.0 d](/filings/0001410636-26-000034.md) | [63.0](/filings/0001410636-26-000063.md) | [90.0](/filings/0001410636-26-000120.md) |
| Net income | $m | [323](/filings/0001410636-25-000022.md) | [171](/filings/0001410636-25-000022.md) | [185](/filings/0001410636-25-000173.md) | [277](/filings/0001410636-25-000173.md) | [350](/filings/0001410636-25-000173.md) | [239](/filings/0001410636-25-000022.md) | [205](/filings/0001410636-26-000120.md) | [289](/filings/0001410636-26-000120.md) | [379](/filings/0001410636-25-000173.md) | [238 d](/filings/0001410636-26-000034.md) | [196](/filings/0001410636-26-000120.md) | [315](/filings/0001410636-26-000120.md) |
| Diluted EPS | $ per share | [1.66](/filings/0001410636-25-000022.md) | [0.88](/filings/0001410636-25-000022.md) | [0.95](/filings/0001410636-25-000083.md) | [1.42](/filings/0001410636-25-000150.md) | [1.80](/filings/0001410636-25-000173.md) | [1.22](/filings/0001410636-25-000022.md) | [1.05](/filings/0001410636-26-000063.md) | [1.48](/filings/0001410636-26-000120.md) | [1.94](/filings/0001410636-25-000173.md) | not reported | [1.00](/filings/0001410636-26-000063.md) | [1.61](/filings/0001410636-26-000120.md) |
| Basic EPS | $ per share | [1.66](/filings/0001410636-25-000022.md) | [0.88](/filings/0001410636-25-000022.md) | [0.95](/filings/0001410636-25-000083.md) | [1.42](/filings/0001410636-25-000150.md) | [1.80](/filings/0001410636-25-000173.md) | [1.22](/filings/0001410636-25-000022.md) | [1.05](/filings/0001410636-26-000063.md) | [1.48](/filings/0001410636-26-000120.md) | [1.94](/filings/0001410636-25-000173.md) | not reported | [1.00](/filings/0001410636-26-000063.md) | [1.61](/filings/0001410636-26-000120.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax, us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.6](/filings/0001410636-24-000187.md) | [0.3](/filings/0001410636-25-000022.md) | [0.6](/filings/0001410636-25-000083.md) | [0.0](/filings/0001410636-25-000150.md) | [0.1](/filings/0001410636-25-000173.md) | [0.1](/filings/0001410636-26-000034.md) | [0.1](/filings/0001410636-26-000063.md) | [0.1](/filings/0001410636-26-000120.md) | [0.2](/filings/0001410636-25-000173.md) | [0.1](/filings/0001410636-26-000120.md) | [0.1](/filings/0001410636-26-000063.md) | [0.2](/filings/0001410636-26-000120.md) |
| Current assets | $bn | [1.8](/filings/0001410636-23-000122.md) | [1.4](/filings/0001410636-25-000022.md) | [1.6](/filings/0001410636-24-000092.md) | [1.2](/filings/0001410636-24-000134.md) | [1.2](/filings/0001410636-24-000187.md) | [1.2](/filings/0001410636-26-000034.md) | [1.2](/filings/0001410636-25-000083.md) | [1.4](/filings/0001410636-25-000150.md) | [1.6](/filings/0001410636-25-000173.md) | [2.2](/filings/0001410636-26-000120.md) | [1.5](/filings/0001410636-26-000063.md) | [1.7](/filings/0001410636-26-000120.md) |
| Total assets | $bn | [29.8](/filings/0001410636-24-000187.md) | [30.3](/filings/0001410636-26-000034.md) | [31.1](/filings/0001410636-25-000083.md) | [31.2](/filings/0001410636-25-000150.md) | [31.8](/filings/0001410636-25-000173.md) | [32.8](/filings/0001410636-26-000034.md) | [33.2](/filings/0001410636-26-000063.md) | [33.9](/filings/0001410636-26-000120.md) | [34.7](/filings/0001410636-25-000173.md) | [35.4](/filings/0001410636-26-000120.md) | [35.3](/filings/0001410636-26-000063.md) | [36.5](/filings/0001410636-26-000120.md) |
| Current liabilities | $bn | [1.7](/filings/0001410636-23-000122.md) | [2.2](/filings/0001410636-25-000022.md) | [1.9](/filings/0001410636-24-000092.md) | [1.8](/filings/0001410636-24-000134.md) | [2.1](/filings/0001410636-24-000187.md) | [3.2](/filings/0001410636-26-000034.md) | [2.4](/filings/0001410636-25-000083.md) | [4.0](/filings/0001410636-25-000150.md) | [3.7](/filings/0001410636-25-000173.md) | [4.7](/filings/0001410636-26-000120.md) | [4.1](/filings/0001410636-26-000063.md) | [3.3](/filings/0001410636-26-000120.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $bn | [0.0](/filings/0001410636-23-000122.md) | [0.2](/filings/0001410636-25-000022.md) | [0.0](/filings/0001410636-24-000092.md) | [0.0](/filings/0001410636-24-000134.md) | [0.2](/filings/0001410636-24-000187.md) | [0.9](/filings/0001410636-26-000034.md) | [1.0](/filings/0001410636-25-000083.md) | [1.6](/filings/0001410636-25-000150.md) | [1.0](/filings/0001410636-25-000173.md) | [1.6](/filings/0001410636-26-000120.md) | [1.4](/filings/0001410636-26-000063.md) | [1.5](/filings/0001410636-26-000120.md) |
| Shareholders' equity | $bn | [9.9](/filings/0001410636-24-000187.md) | [9.8](/filings/0001410636-26-000034.md) | [10.0](/filings/0001410636-25-000173.md) | [10.2](/filings/0001410636-25-000173.md) | [10.4](/filings/0001410636-25-000173.md) | [10.3](/filings/0001410636-26-000120.md) | [10.5](/filings/0001410636-26-000120.md) | [10.7](/filings/0001410636-26-000120.md) | [10.9](/filings/0001410636-25-000173.md) | [10.8](/filings/0001410636-26-000120.md) | [11.0](/filings/0001410636-26-000120.md) | [11.7](/filings/0001410636-26-000120.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: not reported
- Current portion of debt: not reported
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [633 d](/filings/0001410636-24-000187.md) | [527 d](/filings/0001410636-26-000034.md) | [382](/filings/0001410636-25-000083.md) | [345 d](/filings/0001410636-25-000150.md) | [679 d](/filings/0001410636-25-000173.md) | [639 d](/filings/0001410636-26-000034.md) | [331](/filings/0001410636-26-000063.md) | [301 d](/filings/0001410636-26-000120.md) | [764 d](/filings/0001410636-25-000173.md) | [663 d](/filings/0001410636-26-000034.md) | [305](/filings/0001410636-26-000063.md) | [602 d](/filings/0001410636-26-000120.md) |
| Capital expenditure | $m | [626](/filings/0001410636-23-000122.md) | [796 d](/filings/0001410636-26-000034.md) | [609](/filings/0001410636-25-000083.md) | [670 d](/filings/0001410636-25-000150.md) | [683 d](/filings/0001410636-25-000173.md) | [894 d](/filings/0001410636-26-000034.md) | [548](/filings/0001410636-26-000063.md) | [733 d](/filings/0001410636-26-000120.md) | [797 d](/filings/0001410636-25-000173.md) | [1,048 d](/filings/0001410636-26-000034.md) | [659](/filings/0001410636-26-000063.md) | [860 d](/filings/0001410636-26-000120.md) |
| Dividends paid | $m | [138 d](/filings/0001410636-24-000187.md) | [137 d](/filings/0001410636-26-000034.md) | [138](/filings/0001410636-25-000083.md) | [149 d](/filings/0001410636-25-000150.md) | [149 d](/filings/0001410636-25-000173.md) | [149 d](/filings/0001410636-26-000034.md) | [149](/filings/0001410636-26-000063.md) | [162 d](/filings/0001410636-26-000120.md) | [161 d](/filings/0001410636-25-000173.md) | [161 d](/filings/0001410636-26-000034.md) | [162](/filings/0001410636-26-000063.md) | [174 d](/filings/0001410636-26-000120.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [182](/filings/0001410636-23-000122.md) | [186](/filings/0001410636-24-000092.md) | [195](/filings/0001410636-24-000134.md) | [195](/filings/0001410636-24-000187.md) | [195](/filings/0001410636-25-000083.md) | [195](/filings/0001410636-25-000150.md) | [195](/filings/0001410636-25-000173.md) | [195](/filings/0001410636-26-000063.md) | [195](/filings/0001410636-26-000120.md) | [195](/filings/0001410636-25-000173.md) | [195](/filings/0001410636-26-000063.md) | [196](/filings/0001410636-26-000120.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 198,728,989 at 2026-07-20, from the cover of the [10-Q filed 2026-07-29](/filings/0001410636-26-000120.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:39 ET. No prices; not investment advice.